USPTO serial 87158027
LABCORP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 16, 2021
- Examiner
- CHOSID, ROBIN S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with LABCORP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,493*
Plus Government fees of $2,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Laboratory Corporation of America Holdings
Burlington, NC
Other trademarks owned by Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings
Burlington, NC
Other trademarks owned by Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings
Burlington, NC
Other trademarks owned by Laboratory Corporation of America Holdings
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William M. Bryner
William M. Bryner KILPATRICK TOWNSEND & STOCKTON LLP1100 Peachtree Street, Suite 2800Mailstop: IP Docketing - 22Atlanta, GA 30309Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable electronic publications, books, brochures, pamphlets, articles, technical manuals in the field of medical testing | ACTIVE | — |
| 016 | Printed publications, namely, books, brochures, pamphlets, articles, technical manuals, instructional and teaching materials, and reports in the field of medical testing | ACTIVE | — |
| 035 | Regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; economic forecasting and analysis; forecasting drug supplies for clinical trials; recruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; business advisory services, business consultancy services, business data analysis, business information services, business management consulting, business strategy services, market intelligence, market research, marketing services, data collection, data submission, database management, and project management services, all in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology | ACTIVE | Jun 30, 2021 |
| 036 | Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; tracking, monitoring, analyzing, generating, and reporting information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices | ACTIVE | Jun 30, 2021 |
| 042 | Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemical; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; testing of laboratory animals for scientific research purposes; design and development of software for use in conducting animal and biological research in non-clinical pharmaceutical and medical device and development studies; providing online computer databases in the fields of research and development of pharmaceuticals, medical devices, biotechnology, and biochemical; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; food safety testing and consultation related thereto; scientific research and analysis in the fields of food safety, food packaging, and nutritional chemistry; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals and clinical trials; providing online non-downloadable software for tracking, monitoring, analyzing, generating and reporting information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; Acting as an application service provider featuring software for use in database and record management in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; providing non-downloadable software through a web-based portal to collect, organize, and report medical information, medical records, and diagnostic testing records; providing a web-based portal in the fields of medical testing for scientific research purposes, testing for forensic research purposes, testing for quality control purposes, genetic testing for scientific research purposes, and medical and scientific research in the field of, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; providing temporary use of online non-downloadable software for storing, retrieving, accessing, displaying, managing, analyzing, and reviewing information and data in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; consulting services in the fields of testing for drug, alcohol and DNA screening for forensic research purposes and testing for quality control purposes; providing an online computer database in the fields of testing for drug, alcohol and DNA screening for forensic research purposes and testing for quality control purposes; providing a website featuring information in the fields of testing for drug, alcohol and DNA screening for forensic research purposes and testing for quality control purposes; medical testing for quality control | ACTIVE | Jun 30, 2021 |
| 044 | Medical services in the fields of pathology, pharmacology, and immunology; medical and psychological counseling; medical testing for diagnostic, treatment, or screening purposes; medical testing for forensic purposes; genetic testing for medical purposes; medical testing for diagnostic and treatment purposes; consulting services in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care and healthcare; medical consulting in the field of patient management and outcomes, providing an online computer database in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care, and healthcare; providing an online computer database featuring medical information in the field of patient management and outcomes; providing a website featuring information in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care, and healthcare; providing a website featuring medical information in the field of patient management and outcomes | ACTIVE | Jun 30, 2021 |
| 045 | Regulatory compliance consulting in the fields of pharmaceuticals and medical devices; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical devices; regulatory compliance consulting in the field of food safety and nutritional labeling; information and advisory services relating to the foregoing | ACTIVE | Jun 30, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Laboratory Corporation of America Holdings
- Other trademarks owned by Laboratory Corporation of America Holdings
- Other trademarks owned by Laboratory Corporation of America Holdings
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named LABCORP
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 16, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 9, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 8, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 13, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 8, 2021 | IUAF | USE AMENDMENT FILED | — |
| Sep 8, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 27, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 26, 2021 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 26, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 11, 2021 | EXT5 | SOU EXTENSION 5 FILED | — |
| Mar 11, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 12, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 10, 2020 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 10, 2020 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 10, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 12, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 10, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 10, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 10, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 13, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 11, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 11, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 11, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 5, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 12, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 8, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 8, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 8, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 11, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 17, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 17, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 27, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 8, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 8, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 8, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 8, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 8, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 28, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 28, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 28, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2018 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 30, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 9, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 8, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 7, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 7, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 7, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 7, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 9, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 9, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 12, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 8, 2016 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Sep 7, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 5, 2016 | NWAP | NEW APPLICATION ENTERED | — |